Business Description
Structure Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US86366E1064
Share Class Description:
GPCR: ADRDescription
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 208.73 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -63.8 | |||||
| 3-Year EPS without NRI Growth Rate | -56.5 | |||||
| 3-Year FCF Growth Rate | -57.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.58 | |||||
| 9-Day RSI | 35.77 | |||||
| 14-Day RSI | 37.23 | |||||
| 6-1 Month Momentum % | -23.51 | |||||
| 12-1 Month Momentum % | -6.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 27.63 | |||||
| Quick Ratio | 27.63 | |||||
| Cash Ratio | 27.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -22.8 | |||||
| Shareholder Yield % | -32.05 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -19.1 | |||||
| ROA % | -18.21 | |||||
| ROIC % | -1032.88 | |||||
| ROC (Joel Greenblatt) % | -1892 | |||||
| ROCE % | -24.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.8 | |||||
| Price-to-Tangible-Book | 1.8 | |||||
| EV-to-EBIT | -5.1 | |||||
| EV-to-EBITDA | -5.13 | |||||
| EV-to-FCF | -7.03 | |||||
| Price-to-Net-Current-Asset-Value | 1.91 | |||||
| Price-to-Net-Cash | 1.92 | |||||
| Earnings Yield (Greenblatt) % | -19.61 | |||||
| FCF Yield % | -6.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GPCR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Structure Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.19 | ||
| Beta | 0 | ||
| Volatility % | 44.81 | ||
| 14-Day RSI | 37.23 | ||
| 14-Day ATR ($) | 2.449208 | ||
| 20-Day SMA ($) | 31.88375 | ||
| 12-1 Month Momentum % | -6.13 | ||
| 52-Week Range ($) | 26.23 - 62.74 | ||
| Shares Outstanding (Mil) | 57.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Structure Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Structure Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Structure Therapeutics Inc Frequently Asked Questions
What is Structure Therapeutics Inc(GPCR)'s stock price today?
The current price of GPCR is $29.99. The 52 week high of GPCR is $62.74 and 52 week low is $26.23.
When is next earnings date of Structure Therapeutics Inc(GPCR)?
The next earnings date of Structure Therapeutics Inc(GPCR) is 2025-03-07 Est..
Does Structure Therapeutics Inc(GPCR) pay dividends? If so, how much?
Structure Therapeutics Inc(GPCR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers